# Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy

> **NCT00083902** · PHASE2 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 190 (—)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Thalidomide
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT00083902
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-06
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 190 (—)
- **Last updated:** 2010-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00083902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00083902, "Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00083902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*